Insulet (PODD) Research & Development (2010 - 2026)

Insulet (PODD) has reported Research & Development for 17 consecutive years, with $88.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 20.03% year-over-year to $88.1 million; the trailing twelve-month figure through Jun 2026 stood at $345.9 million (up 39.2% YoY), and the FY2025 full-year result was $301.1 million, up 37.11% from the prior year.
• Research & Development slipped to $88.1 million in Q2 2026 per PODD's latest filing, from $89.7 million in the prior quarter.
• Across five years, Research & Development topped out at $90.9 million in Q4 2025 and bottomed at $42.0 million in Q4 2023.
• Historically, Research & Development has averaged $60.2 million across 5 years, with a median of $55.0 million in 2023.
• The widest YoY moves for Research & Development: up 126.87% in 2022, down 63.37% in 2022.
• Over 5 years, Research & Development stood at $49.5 million in 2022, then retreated by 15.15% to $42.0 million in 2023, then jumped by 44.29% to $60.6 million in 2024, then soared by 50.0% to $90.9 million in 2025, then decreased by 3.08% to $88.1 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $88.1 million, $89.7 million, and $90.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.